Compare PHAR & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHAR | LWLG |
|---|---|---|
| Founded | 1988 | 1991 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.4M | 814.0M |
| IPO Year | 2020 | 2011 |
| Metric | PHAR | LWLG |
|---|---|---|
| Price | $10.16 | $5.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.33 | N/A |
| AVG Volume (30 Days) | 33.8K | ★ 2.4M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $236,855.00 |
| Revenue This Year | $10.04 | N/A |
| Revenue Next Year | $2.51 | N/A |
| P/E Ratio | $3,041.22 | ★ N/A |
| Revenue Growth | N/A | ★ 147.74 |
| 52 Week Low | $9.62 | $2.84 |
| 52 Week High | $21.34 | $18.71 |
| Indicator | PHAR | LWLG |
|---|---|---|
| Relative Strength Index (RSI) | 38.04 | 41.94 |
| Support Level | $9.62 | $4.94 |
| Resistance Level | $11.60 | $5.66 |
| Average True Range (ATR) | 0.47 | 0.25 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 9.45 | 44.88 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.